SARAH BROOME: Open Payments
NPI 1174962054 · OAKLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 33 payments from 13 companies in 2025. Trend: 2023 $985 · 2024 $1,137 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 3 | $270 |
| Incyte Corporation | 6 | $227 |
| Regeneron Healthcare Solutions, Inc. | 9 | $213 |
| ABBVIE INC. | 3 | $89 |
| PFIZER INC. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| GENZYME CORPORATION | 2 | $45 |
| Lilly USA, LLC | 1 | $29 |
| UCB, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: Zoryve, DUPIXENT, OPZELURA, SKYRIZI, CIBINQO, COSENTYX, BOTOX, TALTZ.
Industry payments across CA — which companies pay providers there.
